StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report report published on Wednesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 1.0 % BTX stock opened at $2.88 on Wednesday. Brooklyn ImmunoTherapeutics has a 52 week low of $0.17 and a 52 week […]